Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hCT-MSC in Children With Autism Spectrum Disorder
NCT04089579Phase 2Completed
- Sponsor
- Joanne Kurtzberg
- Start
- Oct 2020
- Primary completion
- May 2023
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of wharton's jelly mesenchymal stromal cells in Autism Spectrum Disorder (ASD), sponsored by Joanne Kurtzberg. Started Oct 2020; status: completed.
02
Drugs
wharton's jelly mesenchymal stromal cells
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT04089579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04089579.